doc_id	sent_index	relation_id	relation	trigger	trigger_offset	arg_num	arg_base_np	arg_protein	arg_domain	arg_site	arg_sugar	PSource	SiteSource	NProtein	NID	SiteName	sent_text
35712026	9	89	gly	CD16a	1511:1515	arg1	four N-glycans	CD16a			four N-glycans	PUBTATOR		CD16a	2214		These observations were confirmed using intact protein mass spectrometry that demonstrated the predominant species corresponded to CD16a V158 with five N-glycans, with a smaller contribution from CD16a with four N-glycans.
35327586	5	110	gly	DNA	914:916	arg1	sulfated glycosaminoglycans	DNA			sulfated glycosaminoglycans	Cterm		DNA			A quantification of the amount of DNA, protein, and sulfated glycosaminoglycans (sGAGs) was carried out to determine the efficiency of the extraction in relation to standard decellularization methodologies.
35726720	5	27	gly	SOX9	1134:1137	arg1	sulfated glycosaminoglycan (sGAG) deposition	SOX9			sulfated glycosaminoglycan (sGAG) deposition	PUBTATOR		SOX9	6662		The COL + SF(S) hydrogel exhibited superior stability during cell culture and promoted the gene expression of SOX9 at the early stage and sulfated glycosaminoglycan (sGAG) deposition without any exogenous growth factor.
35270006	6	8	gly	sialylated	795:804	arg1	several fucosylated and sialylated HMOs	several fucosylated and sialylated HMOs				OGER		HMOs	P00540		Relative abundance of human milk bacterial taxa were significantly associated with concentrations of several fucosylated and sialylated HMOs.
35270006	6	56	gly	fucosylated	779:789	arg1	several fucosylated and sialylated HMOs	several fucosylated and sialylated HMOs				OGER		HMOs	P00540		Relative abundance of human milk bacterial taxa were significantly associated with concentrations of several fucosylated and sialylated HMOs.
35572846	8	120	gly	PTMs	1079:1082	arg1	GlcNAc3Man2	PTMs			GlcNAc3Man2	OGER		PTMs	P20962		The mapping of the peptide and glycopeptides using LC-ESI-MS led to the detection of associated PTMs and the direct identification of a glycopeptide, GlcNAc3Man2.
36986193	4	41	gly	fucosylated	576:586	arg1	grouped fucosylated HMOs	grouped fucosylated HMOs				OGER		HMOs	P00540		In this preregistered longitudinal study, we investigated whether human milk 2'-fucosyllactose, 3'-sialyllactose, 6'-sialyllactose, grouped fucosylated HMOs, and grouped sialylated HMOs, assessed during the first twelve postnatal weeks, are associated with better child executive functions at age three years.
36986193	4	76	gly	sialylated	606:615	arg1	grouped sialylated HMOs	grouped sialylated HMOs				OGER		HMOs	P00540		In this preregistered longitudinal study, we investigated whether human milk 2'-fucosyllactose, 3'-sialyllactose, 6'-sialyllactose, grouped fucosylated HMOs, and grouped sialylated HMOs, assessed during the first twelve postnatal weeks, are associated with better child executive functions at age three years.
36813813	1	11	gly	glycoproteins	221:233	arg1	N-linked and O-linked SARS-CoV-2 spike glycoproteins	N-linked and O-linked SARS-CoV-2 spike glycoproteins				PUBTATOR		spike glycoproteins	None		We investigate the electronic response of single-walled carbon nanotubes (SWCNTs) and a carbon nanobelt (CNB) to N-linked and O-linked SARS-CoV-2 spike glycoproteins, using ab initio quantum mechanical approach.
35545925	3	82	gly	integral	408:415	arg1	Peptidoglycan	l			Peptidoglycan	PUBTATOR		l	21832		Peptidoglycan (PG) is an integral component of P. aeruginosa cells that is essential to its survival and a target for antimicrobials.
35153010	4	35	gly	M-N-2-HACC/N-CMCS	735:751	arg1	mannose-modified thiolated chitosan NPs	M-N-2-HACC/N-CMCS NPs			mannose-modified thiolated chitosan NPs	OGER		M-N-2-HACC/N-CMCS NPs	P0C0P6		The electrostatic interaction between the two substances was used to produce mannose-modified thiolated chitosan NPs (M-N-2-HACC/N-CMCS NPs).
35927436	1	59	gly	glycoprotein	71:82	arg1	The envelope glycoprotein GP	The envelope glycoprotein GP				PUBTATOR		envelope glycoprotein GP	100616444		The envelope glycoprotein GP of the ebolaviruses is essential for host cell entry and the primary target of the host antibody response.
35475171	0	61	gly	Variant	71:77	arg1	Distinct Core Glycan	Variant Spike			Distinct Core Glycan	PUBTATOR		Variant Spike	43740568		Distinct Core Glycan and O-Glycoform Utilization of SARS-CoV-2 Omicron Variant Spike Protein RBD Revealed by Top-Down Mass Spectrometry.
35166992	7	58	gly	contained	1142:1150	arg1	α1-2 AND D-Rha	α1-2			D-Rha	PUBTATOR		1-2	28887		WbpX synthesized several products that contained D-Rha in both α1-2 and α1-3 linkages.
36296679	7	39	gly	metalloproteinase	1216:1232	arg1	the glycan structures	matrix metalloproteinase 1			the glycan structures	PUBTATOR		matrix metalloproteinase 1	4312		The mechanism of action appears to involve the carbohydrate-binding capacity of ConGF, and in silico studies suggested that the lectin can interact with the glycan structures of matrix metalloproteinase 1 (MMP1), a prominent protein found in malignant cells, likely explaining the observed effects.
35927436	0	85	gly	glycoprotein	41:52	arg1	the ebolavirus envelope glycoprotein GP	the ebolavirus envelope glycoprotein GP				PUBTATOR		envelope glycoprotein GP	100616444		Glycan shield of the ebolavirus envelope glycoprotein GP.
36551250	3	23	gly	glycoprotein	504:515	arg1	glycosylated human synaptic vesicle glycoprotein A	glycosylated human synaptic vesicle glycoprotein A				Cterm		glycosylated human synaptic vesicle glycoprotein A (hSV2Ag	9900		However, little is known about the molecular mechanisms that control binding of botulinum neurotoxin type F1 (BoNT/F1) to its membrane receptor, glycosylated human synaptic vesicle glycoprotein A (hSV2Ag).
36551250	3	54	gly	glycosylated	468:479	arg1	glycosylated human synaptic vesicle glycoprotein A	glycosylated human synaptic vesicle glycoprotein A (hSV2Ag				Cterm		glycosylated human synaptic vesicle glycoprotein A (hSV2Ag	9900		However, little is known about the molecular mechanisms that control binding of botulinum neurotoxin type F1 (BoNT/F1) to its membrane receptor, glycosylated human synaptic vesicle glycoprotein A (hSV2Ag).
35712026	0	23	gly	N-glycosylated	55:68	arg1	The antibody-binding Fc gamma receptor IIIa	The antibody-binding Fc gamma receptor IIIa				PUBTATOR		Fc gamma receptor IIIa	2214		The antibody-binding Fc gamma receptor IIIa / CD16a is N-glycosylated with high occupancy at all five sites.
35712026	0	23	gly	N-glycosylated	55:68	arg1	CD16a	CD16a				PUBTATOR		CD16a	2214		The antibody-binding Fc gamma receptor IIIa / CD16a is N-glycosylated with high occupancy at all five sites.
36551250	6	65	gly	SV2A	931:934	arg1	N-glycan moiety	SV2A			N-glycan moiety	PUBTATOR		SV2A	9900		Our study suggested that interaction of BoNT/F1 with SV2A is exclusively mediated by N-glycan moiety of SV2A, which interacts with aromatic residues Y898, Y910, F946, Y1059 and H1273 of this toxin.
37365335	6	49	gly	N-glycan	843:850	arg1	PycR1	PycR1			N-glycan	OGER		PycR1	P32322		The N-glycan at N211 in PycR1 significantly increases the affinity to the calcium ion, which in turn regulates the active cavity, making it specifically interact with substrates to accelerate the tandem [4 + 2] cycloaddition.
36550362	0	46	gly	epitopes	82:89	arg1	the SARS-CoV-2 Spike protein	Spike protein			epitopes	PUBTATOR		Spike protein	43740568		Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein.
36550362	7	15	gly	protein	1086:1092	arg1	N-linked glycans	Spike protein			N-linked glycans	PUBTATOR		Spike protein	None		ELISAs with deglycosylated and desialated Spike S1 subunits revealed that cross-reactive antibodies target sialic acid on N-linked glycans of the Spike protein.
35475171	7	52	gly	O-glycoforms	1255:1266	arg1	Omicron O-glycoforms	Omicron O-glycoforms				Cterm		Omicron			Our findings reveal high resolution detail of Omicron O-glycoforms and their utilization to provide direct molecular evidence of proteoform alterations in the Omicron variant which could shed light on how this variant escapes immunological protection.
35131354	10	71	gly	inhomogeneity	1506:1518	arg1	HME-filament	HME-filament				OGER		HME	P39900		The effect of high HME screw speed (100 rpm) resulted in inhomogeneity of HME-filament, which resulted in inconsistency of the printer nozzle extrudate and printed layers.
37365335	3	12	gly	glycosylated	426:437	arg1	PycR1	PycR1				OGER		PycR1	P32322		Here we demonstrate that two calcium-ion-dependent glycosylated enzymes, EupfF and PycR1, independently catalyse sequential, intermolecular Diels-Alder reactions in the biosynthesis of bistropolone-sesquiterpenes.
35927436	2	34	gly	glycans	269:275	arg1	MLD	MLD			glycans	OGER		MLD	O15121		GP is heavily glycosylated with up to 17 N-linked sites, numerous O-linked glycans in its disordered mucin-like domain (MLD), and three predicted C-linked mannosylation sites.
35927436	8	14	gly	glycans	1086:1092	arg1	the conserved sites			the conserved sites	the conserved sites		SpecificSite			sites N257	We find complex glycosylation at the majority of N-linked sites, while the conserved sites N257 and especially N563 are enriched in unprocessed glycans, suggesting a role in host-cell attachment via DC-SIGN/L-SIGN.
36813813	5	10	gly	glycoprotein	784:795	arg1	the O-linked glycoprotein	the O-linked glycoprotein				PUBTATOR		O-linked glycoprotein	None		Since the changes in the CNTs band gaps in the presence of N-linked are about two times larger than the changes in the presence of the O-linked glycoprotein, chiral CNT may distinguish different types of the glycoproteins.
35028784	1	58	gly	heterogeneity	103:115	arg1	elastin	elastin				OGER		elastin	P15502		The heterogeneity and contribution of collagen and elastin to residual stresses have been thoroughly studied, but more recently, glycosaminoglycans (GAGs) also emerged as potential regulators.
36986193	8	7	gly	sialylated	1430:1439	arg1	grouped sialylated HMOs	grouped sialylated HMOs				OGER		HMOs	P00540		Multiple regression analyses were performed in R. Results indicated that concentrations of 2'-fucosyllactose and grouped fucosylated HMOs were associated with better executive functions, while concentrations of grouped sialylated HMOs were associated with worse executive functions at age three years.
36986193	8	47	gly	fucosylated	1332:1342	arg1	grouped fucosylated HMOs	grouped fucosylated HMOs				OGER		HMOs	P00540		Multiple regression analyses were performed in R. Results indicated that concentrations of 2'-fucosyllactose and grouped fucosylated HMOs were associated with better executive functions, while concentrations of grouped sialylated HMOs were associated with worse executive functions at age three years.